288 related articles for article (PubMed ID: 11935242)
1. Survival of children under 3 years old with medulloblastoma: a study from the Mexican Cooperative Group for Childhood Malignancies (AMOHP).
Rivera-Luna R; López E; Rivera-Marquez H; Rivera-Ortegón F; Altamirano-Alvarez E; Mercado G; Covarrubias G; Rueda-Franco F; Marhx-Bracho A; Gutiérrez P
Childs Nerv Syst; 2002 Feb; 18(1-2):38-42. PubMed ID: 11935242
[TBL] [Abstract][Full Text] [Related]
2. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
3. Timing of radiation in children with medulloblastoma/PNET.
Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
[TBL] [Abstract][Full Text] [Related]
5. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
6. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
[TBL] [Abstract][Full Text] [Related]
7. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
[TBL] [Abstract][Full Text] [Related]
8. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of a prospective study on the treatment of medulloblastoma in adults.
Brandes AA; Franceschi E; Tosoni A; Blatt V; Ermani M
Cancer; 2007 Nov; 110(9):2035-41. PubMed ID: 17823910
[TBL] [Abstract][Full Text] [Related]
10. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
11. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma.
Kocsis B; Székely G; Pap L; Németh G
Strahlenther Onkol; 2003 Dec; 179(12):854-9. PubMed ID: 14652675
[TBL] [Abstract][Full Text] [Related]
12. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
13. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
14. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.
Padovani L; Sunyach MP; Perol D; Mercier C; Alapetite C; Haie-Meder C; Hoffstetter S; Muracciole X; Kerr C; Wagner JP; Lagrange JL; Maire JP; Cowen D; Frappaz D; Carrie C
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):433-40. PubMed ID: 17498567
[TBL] [Abstract][Full Text] [Related]
15. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
[TBL] [Abstract][Full Text] [Related]
16. Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
Verlooy J; Mosseri V; Bracard S; Tubiana AL; Kalifa C; Pichon F; Frappaz D; Chastagner P; Pagnier A; Bertozzi AI; Gentet JC; Sariban E; Rialland X; Edan C; Bours D; Zerah M; Le Gales C; Alapetite C; Doz F
Eur J Cancer; 2006 Nov; 42(17):3004-14. PubMed ID: 16956759
[TBL] [Abstract][Full Text] [Related]
17. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
18. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
20. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]